H.R. 8526 is a proposed bill that aims to amend the Public Health Service Act by updating the quality standards for mammography facilities, specifically to incorporate the use of artificial intelligence (AI) systems. This suggests that the bill seeks to ensure that AI technology is used effectively and safely in mammography to potentially improve breast cancer screening and diagnosis.
Media coverage that is positive about H.R. 8526 likely highlights the potential benefits of using AI in mammography, such as increased accuracy in detecting breast cancer, faster diagnosis times, and the ability to assist radiologists in making more informed decisions. Supporters may argue that updating quality standards to include AI could lead to better patient outcomes and more efficient healthcare services.
Negative media coverage of H.R. 8526 might focus on concerns about the reliance on AI technology, such as the risk of errors or biases in AI algorithms that could lead to incorrect diagnoses. Critics may also raise issues about the cost of implementing AI systems in mammography facilities and the need for stringent oversight to ensure patient safety and data privacy.
Although there is significant lobbying activity in the policy area of this bill, there are no direct overlaps detected between the bill's subject matter and the top donor industries of the sponsor, David Schweikert. The largest lobbying contributions come from BAE, Kim & Lee, LLC and MBK Partners, with amounts of $370,000 and $150,000 respectively. However, these entities do not appear to have a direct interest in the subject matter of the bill, which is about updating quality standards for mammography facilities for the use of AI systems. Therefore, the risk of a conflict of interest is low. Voters should be aware that while money does flow into the policy area of this bill, it does not appear to be coming from industries that would directly benefit from the bill's passage.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| BAE, KIM & LEE, LLC | THE MCKEON GROUP, INC. | $370,000 |
| MBK PARTNERS | THE MCKEON GROUP, INC. | $150,000 |
| B. BRAUN MEDICAL INC. | POLSINELLI PC | $70,000 |
| VECTOR | THE MCKEON GROUP, INC. | $40,000 |
| SOLUTION PHILIPPINES, LLC | THE MCKEON GROUP, INC. | $40,000 |
| AMERICAN PHARMACISTS ASSOCIATION | AMERICAN PHARMACISTS ASSOCIATION | $35,000 |
| TRAVERE THERAPEUTICS | THE HEALTH EQUITY STRATEGIES GROUP, LLC | $16,000 |
| D-WAVE GOVERNMENT, INC | THE MCKEON GROUP, INC. | $10,000 |
| NATIONAL ASSOCIATION OF RSVP PROGRAM DIRECTORS | THE SUSQUEHANNA GROUP | $5,000 |
| ROWAN UNIVERSITY | ROWAN UNIVERSITY | undisclosed |
| STR8 CORPORATION | BRODY GROUP L.L.C. PUBLIC AFFAIRS | undisclosed |
| WEST GULF MARITIME ASSOCIATION | WEST GULF MARITIME ASSOCIATION | undisclosed |
| CENTRAL ADMIXTURE PHARMACY SERVICES, INC. | POLSINELLI PC | undisclosed |
| CARTRIDGE TECHNOLOGIES, LLC | CHECKMATE GOVERNMENT RELATIONS | undisclosed |
| BLUE DIAMOND ATOMICS | NATURAL STATE CONSULTING AND STRATEGIES | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding David Schweikert, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
